Abstract
Objective: Long-term cost-effectiveness of app-based treatment
for female stress, urgency, or mixed urinary incontinence (UI) compared
to care-as-usual in primary care.
Design: A pragmatic, randomised controlled, superiority trial.
Setting: Primary care in the Netherlands from 2015 to 2018,
follow-up at 12 months.
Population: Women with ≥2 UI-episodes per week, access to
mobile apps, wanting treatment. 262 women randomised equally to app or
care-as-usual; 89 (68%) and 83 (63%) attended follow-up.
Methods: The standalone app included conservative management
for UI with motivation aids (e.g., reminders). Care-as-usual delivered
according to the Dutch GP guideline for UI.
Main outcome measures: Effectiveness assessed by the change in
symptom severity score (ICIQ-UI-SF) and the change in quality of life
(ICIQ-LUTS-QoL, EQ-5D-5L) on superiority with linear regression on an
intention-to-treat basis. Cost-effectiveness and -utility from a
societal perspective, based on Incontinence Impact Adjusted Life Years
(IIALYs) and Quality Adjusted Life years (QALYs).
Results: Clinically relevant improvement of UI severity for
both app (-2.17 ± 2.81) and care-as-usual (-3.43 ± 3.6), with a
non-significant mean difference of 0.903 (-0.66 to 1.871). Costs were
lower for app-based treatment with \euro-161 (95%CI: -180 to -151)
per year. Cost-effectiveness showed small mean differences in effect for
IIALY (0.04) and QALY (-0.03) and thus larger ICER (-3,696) and ICUR
(\euro6,379).
Conclusion: App-based
treatment is a viable alternative to care-as-usual for UI in primary
care in terms of long-term cost-effectiveness.
Funding: Dutch Organisation for Health Research and Development
(ZonMw: 837001508), sub-funding P.W. Boer Foundation
Tweetable abstract: App-treatment for female urinary
incontinence cost-effective compared to care-as-usual in general
practice after 12 months.
Keywords: App, eHealth, self-management, urinary incontinence,
general practice, primary care, cost-effectiveness, long-term, pragmatic
Trial registration: Dutch Trial Register identifier: Trial
NL4948
(www.trialregister.nl/trial/4948).
The trial was registered before participant inclusion started.